Schedule 13G ownership disclosure

MERSANA THERAPEUTICS INC

Common Stock, par value $0.0001 per share · CUSIP: 59045L106

Event date: 2025-09-30

Filing-level shares
273,579.00
Percent of class
5.48%
  • Schonfeld Strategic Advisors LLC

    Shares: 273,579.00 · Class: 5.48%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193805-25-001600
Form type
SCHEDULE 13G
Filer
Mersana Therapeutics, Inc.
CIK
CIK 1442836
Filed
Nov 14, 2025
Reporting period
Sep 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub